The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT06015243 · UNKNOWN
Trial details
- NCT number
- NCT06015243
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2024-12-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.